Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
GlaxoSmithKline plc
GSK | US
54.44
USD-1.19
-2.14%
GSK | US
Loading StockChartView...
About GlaxoSmithKline plc
Sector
Healthcare
Industry
Drug Manufacturers - Major
Earnings date
30/06/2024
As of date
24/04/2026
Close
54.44
Open
55.22
High
55.26
Low
54.19
GSK plc together with its subsidiaries engages in the research development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom the United States and internationally. It operates through four segments: Pharmaceuticals Pharmaceuticals R&D Vaccines and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas such as infectious disease HIV immunology and respiratory and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford the United Kingdom.
View LessGSK | US
Risk
26.2
Sharpe
1.76
Luna's Score
61/100
Recommendation
Hold
Luna says (GSK | US)
What's Working
Low 6-Month Volatility (<30%)
Largecap (10B - 200B USD)
Good Dividend Yield (2% <= Dividend Yield <= 8%)
Low Market Beta (-0.4 to 0.8)
Strong Operating Margin (> 25%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Debt to Equity (> 0.75)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
23.3%1 month
26.2%3 months
28.9%6 months
26.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
13.16
Fwd. PE
8.33
Price to book
4.23
Debt to equity
1.18
Debt to assets
0.29
Ent. to EBITDA
9.27
Ent. to rev.
2.39
PEG
0.82
Other Fundamentals
EBITDA
10.98B
MarketCap
111.97B
MarketCap(USD)
111.97B
Div. yield
3.97
Op. margin
28.09
Erngs. growth
-28.20
Rev. growth
9.80
Ret. on equity
33.30
Short ratio
3.03
Short perc.
0.72
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
5.38
Range1M
5.78
Range3M
13.13
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.33
Price X volume
274.65M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 9.27 | 21.06 | Cheaper |
| Ent. to Revenue | 2.39 | 5.64 | Cheaper |
| PE Ratio | 13.16 | 41.17 | Cheaper |
| Price to Book | 4.23 | 11.46 | Cheaper |
| Dividend Yield | 3.97 | 3.27 | Leader |
| Std. Deviation (3M) | 28.86 | 39.12 | Lower Risk |
| Debt to Equity | 1.18 | 1.72 | Cheaper |
| Debt to Assets | 0.29 | 0.31 | Par |
| Market Cap | 111.97B | 200.67B | Emerging |
